1. Lipshaw MJ, Eckerle M, Florin TA, Crotty EJ, Lipscomb J, Jacobs J, Rattan MS, Ruddy RM, Shah SS, Ambroggio L. Antibiotic Use and Outcomes in Children in the Emergency Department With Suspected Pneumonia. Pediatrics. 2020;145(4). doi: 10.1542/peds.2019-3138.
2. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-845. doi:10.1056/NEJMoa1405870.
3. Lassi ZS, Padhani ZA, Das JK, Salam RA, Bhutta ZA. Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze. Cochrane Database Syst Rev. 2021; 20. doi: 10.1002/14651858.CD009576.
4. Nascimento-Carvalho CM. Community-acquired pneumonia among children: the latest evidence for an updated management. J Pediatr (Rio J). 2020;96 (1): 29-38. doi: 10.1016/j.jped.2019.08.003.
5. Nascimento-Carvalho AC, Nascimento-Carvalho CM. Clinical management of community-acquired pneumonia in young children. Expert Opin Pharmacother. 2019; 20(4): 435-442. doi: 10.1080/14656566.2018.1552257.
6. Mathur S, Fuchs A, Bielicki J, Van Den Anker J, Sharland M. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018; 38: 66-75. doi: 10.1080/20469047.2017.1409455.
7. World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. 2014. Available from: https://apps.who.int/iris/bitstream/handle/10665/137319/9789241507813_eng.pdf;jsessionid=71BE060EDD018902D3AA86838A8B8FFE?sequence=1
8. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2:ii1-ii23. doi:10.1136/thoraxjnl-2011-200598.
9. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011 Oct;53(7):25-76. doi: 10.1093/cid/cir531.
10. Ginsburg AS, Mvalo T, Nkwopara E, et al. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial. JAMA Pediatr. 2019;173(1):21-28. doi:10.1001/jamapediatrics.2018.3407.
11. Jehan F, Nisar I, Kerai S, et al. Randomized Trial of Amoxicillin for Pneumonia in Pakistan. N Engl J Med. 2020;383(1):24-34. doi:10.1056/NEJMoa1911998.
12. Ginsburg AS, Klugman KP. Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings. Eur Respir J. 2020;56(3):2002773. doi:10.1183/13993003.02773-2020.
13. Phuong NTK, Hoang TT, Van PH, Tu L, Graham SM, Marais BJ. Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region. Pneumonia (Nathan). 2017; 9:7. doi:10.1186/s41479-017-0031-4.